Paper41986366
SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses.
Schmidt SD and 14 others. Nat Commun, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses. Papers, record 41986366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41986366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| SARS-CoV-2 | Major topic |
| Antibodies, Neutralizing | Major topic |
| COVID-19 | Major topic |
| COVID-19 Vaccines | Major topic |
| Humans | |
| Spike Glycoprotein, Coronavirus | |
| Antibodies, Viral | |
| Vaccination | |
| Angiotensin-Converting Enzyme 2 | |
| Neutralization Tests | |
| Animals |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40707428 | HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors. | Nat Commun | 2025 | https://conductscience.org/library/papers/40707428 | PubMed |
| 2 | 32663912 | An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32663912 | PubMed |
| 3 | 39922192 | Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses. | Cell | 2025 | https://conductscience.org/library/papers/39922192 | PubMed |
| 4 | 41345093 | Molecular insights into species-specific ACE2 recognition of coronavirus HKU5. | Nat Commun | 2025 | https://conductscience.org/library/papers/41345093 | PubMed |
| 5 | 34623973 | Cross-protective immunity following coronavirus vaccination and coronavirus infection. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34623973 | PubMed |
| 6 | 32426212 | Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. | Cell Rep | 2020 | https://conductscience.org/library/papers/32426212 | PubMed |
| 7 | 35447072 | mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron. | Cell | 2022 | https://conductscience.org/library/papers/35447072 | PubMed |
| 8 | 35114688 | ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. | Nature | 2022 | https://conductscience.org/library/papers/35114688 | PubMed |
| 9 | 34147139 | Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses. | Cell | 2021 | https://conductscience.org/library/papers/34147139 | PubMed |
| 10 | 41483494 | Genetic distance predicts neutralizing antibody titers for monovalent and bivalent SARS-CoV-2 vaccines. | Vaccine | 2026 | https://conductscience.org/library/papers/41483494 | PubMed |
| 11 | 39532861 | Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. | Nat Commun | 2024 | https://conductscience.org/library/papers/39532861 | PubMed |
| 12 | 41027157 | SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines. | Vaccine | 2025 | https://conductscience.org/library/papers/41027157 | PubMed |
| 13 | 37075127 | Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37075127 | PubMed |
| 14 | 33270381 | Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33270381 | PubMed |
| 15 | 36357712 | Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial. | Nat Microbiol | 2022 | https://conductscience.org/library/papers/36357712 | PubMed |
| 16 | 39466880 | Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39466880 | PubMed |
| 17 | 34263709 | Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor. | Emerg Microbes Infect | 2021 | https://conductscience.org/library/papers/34263709 | PubMed |
| 18 | 40934083 | Molecular basis of sarbecovirus evolution and receptor tropism in natural hosts, potential intermediate hosts, and humans. | Cell Rep | 2025 | https://conductscience.org/library/papers/40934083 | PubMed |
| 19 | 39402048 | Sarbecovirus RBD indels and specific residues dictating multi-species ACE2 adaptiveness. | Nat Commun | 2024 | https://conductscience.org/library/papers/39402048 | PubMed |
| 20 | 33164751 | ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. | Elife | 2020 | https://conductscience.org/library/papers/33164751 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42845495 | Vaccine imprinting drives increased SARS-CoV-2 variant infection in children. | bioRxiv | 2026 | https://conductscience.org/library/papers/42845495 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41986366
GET https://conductscience.org/api/papers/v1/41986366/references?page=2